These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3818231)

  • 1. Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.
    Braich TA; Salmon SE; Robertone A; Alberts DS; Jones SE; Miller TP; Garewal HS
    Invest New Drugs; 1986; 4(3):269-74. PubMed ID: 3818231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
    Ringenberg QS; Propert KJ; Muss HB; Weiss RB; Schilsky RL; Modeas C; Perry MC; Norton L; Green M
    Invest New Drugs; 1990 May; 8(2):221-6. PubMed ID: 2166722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esorubicin (4'-deoxydoxorubicin, NSC 267469) in advanced breast cancer. A phase II study of the CALGB.
    Muss HB; Van Echo D; Korzun AH; Henderson IC; Campbell T; Vogelzang NJ; Rice MA; Wood W
    Am J Clin Oncol; 1990 Jun; 13(3):233-7. PubMed ID: 2346128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancers.
    Sessa C; Calabresi F; Cavalli F; Cerny T; Liati P; Skovsgaard T; Sorio R; Kaye SB
    Ann Oncol; 1991; 2(10):727-31. PubMed ID: 1666296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancer.
    Rigas JR; Kris MG; Gralla RJ; Heelan RT; Marks LD
    Invest New Drugs; 1991 May; 9(2):187-90. PubMed ID: 1651908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group study.
    Vaughn CB; Salmon SE; Fleming TR
    Invest New Drugs; 1990 Feb; 8(1):81-5. PubMed ID: 2188929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685).
    Hochster H; Hunt M; Green M; Parkinson D; Smith T
    Invest New Drugs; 1990 Aug; 8(3):329-32. PubMed ID: 2272773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trials of tetrahydropyranyl-adriamycin (Pirarubicin) on renal and colon carcinoma, melanoma, and soft tissue sarcoma.
    Roché H; Guiochet N; Kerbrat P; Rebattu P; Fargeot P; Cattan A; Armand JP; Keiling R; Lentz MA; Van Glabeke M
    Am J Clin Oncol; 1993 Apr; 16(2):137-9. PubMed ID: 8452105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.
    McGuire WP; Blessing JA; Berman ML
    Invest New Drugs; 1989 Nov; 7(4):333-6. PubMed ID: 2557300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.
    Hurteloup P; Chollet P; Roche H; Chevallier B; Cappelaere P; Van Glabbece M; Hayat M; Armand JP
    Eur J Cancer Clin Oncol; 1989 Jun; 25(6):995-6. PubMed ID: 2753061
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of 4'-deoxydoxorubicin in advanced colorectal cancer.
    Falkson G; Vorobiof DA
    Invest New Drugs; 1986; 4(2):165-9. PubMed ID: 3733376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma.
    Frustaci S; Gasparini G; Veronesi A; Tirelli U; Pacciarini MA; Crivellari D; Zagonel V; Monfardini S
    Invest New Drugs; 1987; 5(3):307-9. PubMed ID: 3667167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.
    Rose C; Lad TE; Kilton LJ; Schor J; Rosen ST; Rossof AH; Blough RR; Johnson CM
    Invest New Drugs; 1990 Feb; 8(1):97-9. PubMed ID: 2160920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemia.
    Dutcher JP; Riggs CE; Strauman JJ; Link B; Wiernik PH
    Clin Pharmacol Ther; 1989 Apr; 45(4):424-8. PubMed ID: 2702800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of 4'-deoxydoxorubicin (esorubicin) in hormone resistant prostate cancer.
    Braich T; Ahmann FR; Garewal HS; Robertone A; Salmon SE
    Invest New Drugs; 1986; 4(2):193-6. PubMed ID: 3733379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anthracycline analogs in advanced breast cancer.
    Bonfante V; Ferrari L; Brambilla C; Rossi A; Villani F; Crippa F; Valagussa P; Bonadonna G
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1379-85. PubMed ID: 3470179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
    Cersosimo RJ; Hong WK
    J Clin Oncol; 1986 Mar; 4(3):425-39. PubMed ID: 3005521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group study.
    Alberts DS; Mason-Liddil N; Stock-Novack D; O'Toole RV; Abbott TM; Salmon SE
    Am J Clin Oncol; 1992 Apr; 15(2):146-9. PubMed ID: 1553903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
    Conley BA; Hornedo J; Abrams J; Eisenberger M; Hiponia D; Aisner J; Van Echo DA
    Cancer Treat Rep; 1987 Sep; 71(9):861-2. PubMed ID: 3040246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.